Association of the DTNBP1 locus with schizophrenia in a U.S. population.

Linkage and association studies have recently implicated dystrobrevin-binding protein 1 (DTNBP1) in the etiology of schizophrenia. We analyzed seven previously tested DTNBP1 single-nucleotide polymorphisms (SNPs) in a cohort of 524 individuals with schizophrenia or schizoaffective disorder and 573 control subjects. The minor alleles of three SNPs (P1578, P1763, and P1765) were positively associated with the diagnosis of schizophrenia or schizoaffective disorder in the white subset of the study cohort (258 cases, 467 controls), with P1578 showing the most significant association (odds ratio 1.76, P =.0026). The same three SNPs were also associated in a smaller Hispanic subset (51 cases, 32 controls). No association was observed in the African American subset (215 cases, 74 controls). A stratified analysis of the white and Hispanic subsets showed association with the minor alleles of four SNPs (P1578, P1763, P1320, and P1765). Again, the most significant association was observed for P1578 (P =.0006). Haplotype analysis supported these findings, with a single risk haplotype significantly overrepresented in the white sample (P =.005). Our study provides further evidence for a role of the DTNBP1 gene in the genetic etiology of schizophrenia.

[1]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[2]  K. Campbell,et al.  Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.

[3]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[4]  Thomas G Schulze,et al.  The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. , 2003, American journal of human genetics.

[5]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[6]  M. Gill,et al.  No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study , 2003, Schizophrenia Research.

[7]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[8]  G. Feng,et al.  Family-based association study of DTNBP1 in 6p22.3 and schizophrenia , 2003, Molecular Psychiatry.

[9]  G. Thaker,et al.  CURRENT PROGRESS IN SCHIZOPHRENIA RESEARCH: EYE MOVEMENT ABNORMALITIES IN SCHIZOPHRENIA: WHAT IS THE NATURE OF THE DEFICIT? , 2002, The Journal of nervous and mental disease.

[10]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[11]  M. Mehler.  Brain dystrophin, neurogenetics and mental retardation , 2000, Brain Research Reviews.

[12]  P. Sasieni.  From genotypes to genes: doubling the sample size. , 1997, Biometrics.

[13]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[14]  T. Oltmanns.  Current Progress in Schizophrenia Research. , 1987 .

[15]  D. Pfaff,et al.  Genetic Influences on Neural and Behavioral Functions , 1999 .

[16]  J. Pankow,et al.  Regarding "Testing for population subdivision and association in four case-control studies". , 2002, American journal of human genetics.

[17]  M J Owen,et al.  Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). , 2004, Archives of general psychiatry.

[18]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[19]  I. Gottesman,et al.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.

[20]  K. North,et al.  Cognitive dysfunction as the major presenting feature of Becker's muscular dystrophy , 1996, Neurology.

[21]  P. McGuffin,et al.  Genetic basis of schizophrenia , 1995, The Lancet.

[22]  K. Lunetta,et al.  Testing for population subdivision and association in four case-control studies. , 2002, American journal of human genetics.

[23]  N. Risch.  Linkage strategies for genetically complex traits. I. Multilocus models. , 1990, American journal of human genetics.

[24]  Raquel E Gur,et al.  Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. , 2004, The Journal of clinical investigation.

[25]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[26]  Y. Stern,et al.  Poor verbal working memory across intellectual level in boys with Duchenne dystrophy , 2000, Neurology.

[27]  J. Morley,et al.  Brain function in Duchenne muscular dystrophy. , 2002, Brain : a journal of neurology.

[28]  Ivan Nikolov,et al.  Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria , 2004, Biological Psychiatry.

[29]  Tao Li,et al.  The genetics of schizophrenia: glutamate not dopamine? , 2003, European journal of pharmacology.

[30]  Sergio Fonda,et al.  Saccadic eye movements are impaired in Duchenne Muscular Dystrophy , 2004, Documenta Ophthalmologica.

[31]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[32]  P. Sullivan,et al.  Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. , 2003, Molecular Psychiatry.

[33]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[34]  P. Visscher,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.

[35]  Francesco Muntoni,et al.  Dystrophin and mutations: one gene, several proteins, multiple phenotypes , 2003, The Lancet Neurology.

[36]  W. G. Hill,et al.  Estimation of linkage disequilibrium in randomly mating populations , 1974, Heredity.

[37]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.